This message was sent to ##Email##
|
|
|
| |
| HEALTH CARE NEWS AND UPDATES |
Medscape
An unexpected finding in women with estrogen receptor-positive (ER+) metastatic breast cancer (MBC) is the emergence of acquired mutations in HER2.
These mutations explain some of the resistance to hormone-directed therapy that is seen in these patients, and the new finding could offer a new approach to clinical management, researchers said at a media preview for the American Association for Cancer Research (AACR) 2018 Annual Meeting.
READ MORE
TechCrunch
Cancer remains the one counterpoint to the march of medical progress that has scored human history over the last 200 years.
Last year 600,920 people in the U.S. died from cancer, and another 1.7 million received an initial diagnosis of the disease. Globally, one in six people die from cancer, according to the World Health Organization.
In the past decade, research in the field has expanded the possible treatments of the disease from surgery (which was the only option until the 20th century), radiotherapy, chemotherapy and hormonal therapy.
READ MORE
|
Promoted by
|
|
|
|
 |
Dark Daily
With growing regularity, new discoveries about the human microbiome have been reported in scientific journals and the media. Some of these discoveries have led to innovations in clinical laboratory tests over the past few years. Dark Daily reported on these breakthroughs, which include: improved cancer drugs, life extension, personalized medical treatments (AKA, precision medicine), genetic databases and women’s health.
READ MORE
ScienceDaily
Two new studies use new models to identify genetic targets and test promising treatments in adrenal cancer. One patient was treated with the immunotherapy pembrolizumab and now, more than a year after starting treatment, remains on the drug with 77 percent tumor reduction and no new metastases.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our ihcDirect® product list.
|
|
Wired
This year, nearly 1.7 million Americans will be diagnosed with cancer. Most will find out in the usual way: after having tiny blobs of tissue slurped up through a needle, smeared and stained on a slide and put under the discerning eye of a pathologist. But starting this week, Medicare patients with advanced cancers will have access to a more 21st century diagnostic: Their cells can now be sequenced, matching patients with the drugs most likely to make a difference.
READ MORE
Medscape
Cannabis, or marijuana, may improve a variety of cancer-related symptoms, including nausea and vomiting, sleep disorders, pain, anxiety and depression, conclude the authors of a 2960-patient observational study from Israel.
The study was published online March 5 in the European Journal of Internal Medicine.
It provides a large-scale portrait of who used medical cannabis for what cancers, and what benefits they derived during a six-month period.
READ MORE
 |
|
Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast. Donate today.
|
|
ScienceDaily
DNA has an important job — it tells your cells which proteins to make. Now, a research team at the University of Delaware has developed technology to program strands of DNA into switches that turn proteins on and off.
READ MORE
Genetic Engineering & Biotechnology News
When President Obama announced the Precision Medicine Initiative at the State of the Union in 2015, it recognized more than a decade of work that scientists and medical researchers had already committed to identifying the underlying genetic causes of diseases and specific pathways to treatment. To date, there have been measurable gains in the application of precision medicine approaches across a series of therapeutic areas, most notably oncology.
READ MORE
|
|
|
|
|
| |
| ACS CANCER PROGRAMS UPDATES |
Cancer Program- NCDB
An update to your CQIP 2017 Annual Report has been released impacting Slide 49 - Number of Major Surgical Resections for Selected Cancers, 2013 - 2015 - My Facility, “Lung Resection” includes all lung cancer resections for major surgeries (Surgical Procedure of Primary Site at This Facility / Codes 30 through 80 / NAACCR Item #670) and Slide 53 - NSCLC Resections, Unadjusted 30, 90 Day Mortality, 95 percent CI, 2013 - 2015 My Facility vs. All CoC and CoC High Volume, changed to include only Non-Small Cell Lung (NSCLC) cases. Slides that are impacted are denoted as “Updated March 2018”. The remaining CQIP slides remain unchanged.
If you have any questions please contact ncdbcqip@facs.org.
ACS-CRP
The Commission on Cancer (CoC) initiated a pilot study at 20 CoC-accredited facilities in the fall of 2017 as a component of the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) clinical trial (PIs: Drs. Shelley Hwang, Ann Partridge, Alastair Thompson). The study examines the risks and benefits of active surveillance compared with usual care for patients diagnosed with low risk ductal carcinoma in situ (DCIS), commonly known as stage 0 breast cancer. The pilot study concluded Jan. 1, 2018. Following data analysis, a CoC Special Study will be launched in spring 2018 to investigate outcomes from DCIS treatment retrospectively.
READ MORE
NAPBC
The National Accreditation Program for Breast Centers (NAPBC) has released the 2018 NAPBC Standards Manual.
You can download a PDF of the manual from the NAPBC Standards web page.
Click the 2018 NAPBC Standards Manual link at the top of the standards web page. If your browser is set to auto-download, check the downloads folder on your computer after clicking the link.
The 2018 NAPBC Standards Manual will be available online and as a PDF. The NAPBC will not have printed copies of the manual for purchase.
Please contact us at NAPBC@facs.org with any questions or comments.
READ MORE
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
American College of Surgeons
The American College of Surgeons (ACS) is pleased to announce that Optimal Resources for Surgical Quality and Safety is now available for purchase. This manual is intended to serve as a trusted resource for surgical leaders seeking to improve patient care in their institutions, departments and practices. It introduces key concepts in quality, safety and reliability and explores the essential elements that all hospitals should have in place to ensure the delivery of patient-centered care. Specific topics covered include the following: the domains and phases of surgical care, peer and case review, responsibilities of the Surgical Quality Officer, institutional infrastructure, privileging and credentialing, high reliability, applications to the unique surgical disciplines, data analytics, clinical practice guidelines, quality collaboratives and education and training. The manual also includes a look at some of the “soft skills” that influence quality and safety in health care, as well as the individual surgeon’s responsibility to the patient, colleagues and the next generation of surgeons. Optimal Resources for Surgical Quality and Safety is available for $44.95 (includes shipping) for single copies (up to a quantity of nine) or $39.95 (includes shipping) for per copy for 10 copies or more on the ACS website.
| IMPORTANT DATES AND DEADLINES |
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
